Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison D Augustine

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Vaccine|April 26, 2025
Collaborative influenza vaccine innovation centers (CIVICs) programKentner L Singleton, Diane J Post, Alison D Augustine, et al.
Viral Immunology|June 23, 2010
NIAID workshop on Flavivirus immunityAlison D Augustine, M Cristina Cassetti, Francis A Ennis, et al.
Medrxiv : the Preprint Server for Health Sciences|February 26, 2024
Host-Microbe Multiomic Profiling Reveals Age-Dependent COVID-19 ImmunopathologyHoang Van Phan, Alexandra Tsitsiklis, Cole P Maguire, et al.
Science Translational Medicine|April 17, 2024
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathologyHoang Van Phan, Alexandra Tsitsiklis, Cole P Maguire, et al.
JCI Insight|November 10, 2025
Minimalistic transcriptomic signatures permit accurate early prediction of COVID-19 mortalityRithwik Narendra, Emily C Lydon, Hoang Van Phan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
Minimalistic Transcriptomic Signatures Permit Accurate Early Prediction of COVID-19 MortalityRithwik Narendra, Emily C Lydon, Hoang Van Phan, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participantsJeremy P Gygi, Cole Maguire, Ravi K Patel, et al.
Ebiomedicine|November 2, 2023
Corrigendum to "Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study" [eBioMedicine 83 (2022) 104208]Al Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2025
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC studyKoji Abe, Tyson H Holmes, Tran T Nguyen, et al.
Ebiomedicine|August 11, 2022
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC studyAl Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Vaccine|April 26, 2025
Collaborative influenza vaccine innovation centers (CIVICs) programKentner L Singleton, Diane J Post, Alison D Augustine, et al.
Viral Immunology|June 23, 2010
NIAID workshop on Flavivirus immunityAlison D Augustine, M Cristina Cassetti, Francis A Ennis, et al.
Medrxiv : the Preprint Server for Health Sciences|February 26, 2024
Host-Microbe Multiomic Profiling Reveals Age-Dependent COVID-19 ImmunopathologyHoang Van Phan, Alexandra Tsitsiklis, Cole P Maguire, et al.
Science Translational Medicine|April 17, 2024
Host-microbe multiomic profiling reveals age-dependent immune dysregulation associated with COVID-19 immunopathologyHoang Van Phan, Alexandra Tsitsiklis, Cole P Maguire, et al.
JCI Insight|November 10, 2025
Minimalistic transcriptomic signatures permit accurate early prediction of COVID-19 mortalityRithwik Narendra, Emily C Lydon, Hoang Van Phan, et al.
Medrxiv : the Preprint Server for Health Sciences|June 6, 2025
Minimalistic Transcriptomic Signatures Permit Accurate Early Prediction of COVID-19 MortalityRithwik Narendra, Emily C Lydon, Hoang Van Phan, et al.
Biorxiv : the Preprint Server for Biology|November 21, 2023
Integrated longitudinal multi-omics study identifies immune programs associated with COVID-19 severity and mortality in 1152 hospitalized participantsJeremy P Gygi, Cole Maguire, Ravi K Patel, et al.
Ebiomedicine|November 2, 2023
Corrigendum to "Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study" [eBioMedicine 83 (2022) 104208]Al Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 30, 2025
Evaluating COVID-19 severity prediction and immune dynamics with NULISAseq: Insights from the IMPACC studyKoji Abe, Tyson H Holmes, Tran T Nguyen, et al.
Ebiomedicine|August 11, 2022
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: Results from the IMPACC studyAl Ozonoff, Joanna Schaenman, Naresh Doni Jayavelu, et al.
Pageof 3